Related Experiment Video
Updated: Jun 2, 2026
10:29
Christopher Hughes: An in vitro model for the Study of Angiogenesis (Interview)
Published on: April 28, 2007
Hughes-Stovin syndrome.
1Medical College, Aga Khan University, Stadium Road, Karachi 74800, Pakistan.
Orphanet Journal of Rare Diseases
|April 15, 2011
Summary
Hughes-Stovin Syndrome (HSS) is a rare disorder of thrombophlebitis and pulmonary aneurysms. Early diagnosis and intervention are crucial for improving the prognosis of this condition.
Area of Science:
- Vascular Medicine
- Rare Diseases
- Pulmonology
Background:
- Hughes-Stovin Syndrome (HSS) is an exceptionally rare condition characterized by thrombophlebitis and pulmonary/bronchial aneurysms.
- Fewer than 40 cases are documented in English medical literature, with unknown etiology and pathogenesis, possibly linked to infections or angiodysplasia.
- HSS is sometimes considered a variant of Behcet's disease (BD).
Purpose of the Study:
- To summarize the clinical presentation, management, and prognosis of Hughes-Stovin Syndrome.
- To highlight the diagnostic challenges and therapeutic considerations for HSS.
- To identify areas for future research in understanding HSS etiology and treatment.
Main Methods:
- Literature review of published cases of Hughes-Stovin Syndrome.
- Analysis of clinical features, diagnostic approaches, and treatment outcomes.
- Discussion of current management strategies, including medical and surgical options.
Main Results:
- HSS presents with symptoms like cough, dyspnea, fever, chest pain, and hemoptysis.
- Management involves steroids and cytotoxic agents (e.g., cyclophosphamide); anticoagulants are generally contraindicated.
- Surgical options like lobectomy/pneumectomy or transcatheter embolization exist, but aneurysmal rupture remains a leading cause of death.
Conclusions:
- Early diagnosis and timely intervention are critical for improving the poor prognosis of HSS.
- Further research is needed to elucidate the genetic, etiologic, and pathologic basis of HSS.
- Development of improved therapies and clearer guidelines for anticoagulation in HSS are necessary.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
02:33Hedgehog Signaling Pathway
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...